$TMED

Health In Tech (HIT) reported its Q2 2025 earnings, showing a significant increase in revenue driven by growth in telehealth services. The company also highlighted strategic partnerships with insurance providers that will expand its market reach. However, increased operational costs related to new technology investments have raised concerns among investors. Overall, HIT's performance has led to a bullish outlook for its stock, despite some caution surrounding potential future expenses. Analysts have updated their price targets positively in response to the earnings results.